The Novavax vaccine had 90% efficacy against COVID-19 ≥l7 d after the second dose

Research output: Contribution to journal › Comment/debate

4 Scopus citations

Access to Document

@article{a93a60be582c45b5ac6437591d90790c,

title = "The Novavax vaccine had 90% efficacy against COVID-19 ≥l7 d after the second dose",

author = "Sacks, {Henry S.}",

note = "Funding Information: Novavax.",

year = "2021",

month = nov,

day = "1",

doi = "10.7326/ACPJ202111160-124",

language = "English",

volume = "174",

pages = "JC124",

journal = "Annals of Internal Medicine",

issn = "0003-4819",

publisher = "American College of Physicians",

number = "11",

}

TY - JOUR

T1 - The Novavax vaccine had 90% efficacy against COVID-19 ≥l7 d after the second dose

AU - Sacks, Henry S.

N1 - Funding Information: Novavax.

PY - 2021/11/1

Y1 - 2021/11/1

UR - http://www.scopus.com/inward/record.url?scp=85119653250&partnerID=8YFLogxK

U2 - 10.7326/ACPJ202111160-124

DO - 10.7326/ACPJ202111160-124

M3 - Comment/debate

C2 - 34724399

AN - SCOPUS:85119653250

SN - 0003-4819

VL - 174

SP - JC124

JO - Annals of Internal Medicine

JF - Annals of Internal Medicine

IS - 11

ER -